India Diabetes Care Drugs Market Report 2020: By Key Players, Trends, Share and Forecast 2020-2026
The Indian diabetes care drugs market is
anticipated to grow at a significant CAGR during the forecast period
(2020-2026). The key factor that drives the growth of the market is the rising
prevalence of diabetes in the country. India has the second-largest number of
adults with diabetes globally. As per the IDF, there were 77 million adults
(20-79 years) suffering from diabetes in 2019.
Moreover, the rising aging population is
also among one of the key drivers of the Indian diabetes care drugs industry.
As per the World Bank, there is more than 83 million elderly population (65 and
above) that is over 6.1% of the total population. As older peoples are more
prone to diseases such as diabetes, joint pain among others which creates scope
for the market.
(Get 15% Discount on Buying this Report)
A full report of India Diabetes Care Drugs Market
is available at: https://www.omrglobal.com/industry-reports/india-diabetes-care-drugs-market
As per the projections by the IDF, the
diabetes prevalence is likely to reach more than 101.0 million in 2030 and
further reach 134.2 million in 2045. Furthermore, the increased spending on
healthcare and particularly diabetes is also likely to support the growth of
the market over the forecast period. As per the World Economic Forum (WEF), the
GDP of the country in 2018 was $2.9 trillion. According to the National Health
Portal of India, India spends only 1.02% of its GDP on public health. The
presence of the key players also supports the growth of the market over the
forecast period.
To
learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/india-diabetes-care-drugs-market
Market
Coverage
·
Market number available for – 2019-2026
·
Base year- 2019
·
Forecast period- 2020-2026
·
Segment Covered- By Drug Class
·
Region Covered- India
·
Competitive Landscape- Eli Lilly & Co.,
Johnson & Johnson Services Inc., Merck & Co. Inc., Sanofi SA, Sun
Pharmaceuticals Industries Ltd., and Takeda Pharmaceuticals Industries Ltd.
Key
questions addressed by the report
·
What is the market growth rate?
·
Which segment region dominates the market in the
base year?
·
Which segment will project the fastest growth in
the market?
·
How COVID-19 impacted the market?
o
Recovery Timeline
o
Deviation from the pre-COVID forecast
o
Most affected segment
·
Who is the leader in the market?
·
How players are addressing challenges to sustain
growth?
·
Where is the investment opportunity?
India
Diabetes Care Drugs Market – Segmentation
By
Drug Class
·
Insulins
·
Non-Insulin Injectable Drugs
·
Oral Anti-Diabetic Drugs
·
Combination Drugs
For
more customized data, request for report customization @ https://www.omrglobal.com/report-customization/india-diabetes-care-drugs-market
Company Profiles
·
AstraZeneca Plc
·
Eli Lilly and Co.
·
Johnson &
Johnson Services Inc.
·
Merck & Co.
Inc.
·
Mylan NV
·
Novo Nordisk A/S
·
Pfizer Inc.
·
Sanofi SA
·
Sun Pharmaceuticals
Industries Ltd.
·
Takeda
Pharmaceuticals Industries Ltd.
·
Teva
Pharmaceuticals Industries Ltd.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more
than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and
after purchasing your report.
About Orion Market Research
Orion
Market Research (OMR) is a market research and consulting company known for its
crisp and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Contact
Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no:
+91 780-304-0404
Company
Name: Orion Market Research
0 Comments